Ta-2 adrenergic receptor (ADRB2), and catechol-O-methyltransferase (COMT) have all been demonstrated to influence acute discomfort
Ta-2 adrenergic receptor (ADRB2), and catechol-O-methyltransferase (COMT) have all been demonstrated to influence acute discomfort sensitivity7,9,10,13,16,38,49, chronic discomfort intensity11,19,28,34, and threat for development of chronic pain conditions6,9,12,15,19,29,39,43. Prior work also…